CVR number 29852162
Industry 75.0000 Veterinary activities

RYNKEBY HESTEKLINIK ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  7.7% 4.1% 4.9% 3.0% 2.7%  
Credit score (0-100)  31 48 43 56 60  
Credit rating  BB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Gross profit  1,264 1,998 1,941 2,167 2,654  
EBITDA  303 1,136 785 778 1,157  
EBIT  77.2 904 575 562 923  
Pre-tax profit (PTP)  51.4 876.8 533.8 548.4 909.4  
Net earnings  40.1 686.0 417.2 428.8 709.6  
Pre-tax profit without non-rec. items  51.4 877 534 548 909  
 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Tangible assets total  879 1,297 1,087 1,099 1,032  
Shareholders equity total  368 1,554 1,471 1,600 2,009  
Interest-bearing liabilities  1,236 0.0 0.0 1,375 1,123  
Balance sheet total (assets)  2,268 3,326 3,300 3,586 3,964  
Net Debt  779 -1,011 -943 223 -217  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,264 1,998 1,941 2,167 2,654  
Gross profit growth  -19.2% 58.1% -2.8% 11.6% 22.5%  
Employees  3 2 3 3 3  
Employee growth %  50.0% -33.3% 50.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,268 3,326 3,300 3,586 3,964  
Balance sheet change%  -3.5% 46.6% -0.8% 8.6% 10.6%  
Added value  303.1 1,136.3 784.8 771.9 1,156.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -397 186 -420 -205 -301  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  6.1% 45.3% 29.6% 25.9% 34.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  5.2% 33.5% 17.9% 17.5% 25.4%  
ROI %  6.7% 56.7% 37.3% 26.2% 30.7%  
ROE %  8.5% 71.4% 27.6% 27.9% 39.3%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  16.2% 46.7% 44.6% 44.6% 50.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  257.0% -88.9% -120.1% 28.6% -18.8%  
Gearing %  335.9% 0.0% 0.0% 85.9% 55.9%  
Net interest  0 0 0 0 0  
Financing costs %  5.5% 9.6% 0.0% 7.9% 4.1%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.6 0.9 1.0 1.0 1.3  
Current Ratio  0.8 1.2 1.3 1.3 1.6  
Cash and cash equivalent  456.7 1,010.6 942.6 1,152.3 1,340.6  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -306.8 334.4 461.4 573.3 1,044.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  101 568 262 257 386  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  101 568 262 259 386  
EBIT / employee  26 452 192 187 308  
Net earnings / employee  13 343 139 143 237